LIfT BioSciences Aims To Revolutionize Cancer Treatment with Bioengineered Immune Cells
LIfT BioSciences, a pioneering biotech startup, is advancing the field of cancer treatment by harnessing the body's oldest immune cells to tackle one of medicine's most formidable challenges. Although cancer remains one of the leading causes of mortality worldwide, innovations in immunotherapy and engineered cell therapies offer new hope.